222 / 464
222
POSTERS AND ELECTRONIC POSTERS
| Programme and Exhibition Guide
ELECTRONIC POSTERS
L. Sommers (The Netherlands), R. Steenbakkers, H. Bijl,
J. Vemer-van den Hoek, J. Roodenburg, S. Oosting, S. De Rooij, J. Langendijk
EP-1033
> Significance of mutant p53 and Ki67 as predictive biomarkers post
Chemo-RT in locally advanced HNSCC
P. Baskaran Shanmuga (India), K. Periasamy, S. Sharma, G.K. Singh,
K. Pratap, P. Singh, V. Yadav, A.K. Mandal, K.T. Bhowmik
EP-1034
> Dose-volume analysis of the hypoglossal nerve and its correlation with
Dysarthria-Dysphagia Syndrome
F. Chen (China), R. Ren
EP-1035
> 18F-FDG-PET in guiding dose-painting with IMRT in oropharyngeal
tumours (FiGaRO) – swallow qesults
C. Doughty (UK), J. Dunton, A. Michaelidou, M. Lei, T. Guerrero Urbano
EP-1036
> Chronic radiation-associated dysphagia (RAD) after curative
reirradiation in head and neck cancer
L. Gutierrez Bayard (Spain), M. Salas Buzón, E. Porras Alonso,
S. Garduño Sánchez, M. Macias, L. Ingunza Barón, E. Gonzalez Calvo,
I. Villanego Beltran, V. Diaz Diaz
EP-1037
> Intraoperative electron beam radiotherapy for locoregionally recurrent
head and neck cancer
P. Wald (USA), J. Grecula, A. Bhatt, V. Diavolitsis, T. Teknos, M. Old,
J. Rocco, A. Agarwal, E. Ozer, R. Carrau, D. Blakaj
EP-1038
> CTV growth evaluation for involved site neck lymphoma RT if pre-
chemo RT position PET-CT is absent
D. Bird (UK), C. Patel, A. Scarsbrook, V. Cosgrove, E. Thomas, D. Gilson,
R. Prestwich
EP-1039
> Identifying risk factors for L’Hermitte’s syndrome after chemo-IMRT
for head and neck cancer
H. Laidley (UK), D. Noble, G. Barnett, R. Jena, N. Burnet
EP-1040
> The preliminary report of PG2 in improving QoL of pharyngeal cancer
patients in chemoradiotherapy
H.M. Wang (Taiwan), J.R. Lin, C.H. Hsieh, C.L. Hsu, C.Y. Lin,
J.T.C. Chang
EP-1041
> Olfactory neuroblastoma – 10-year experience with VMAT
radiotherapy
H. Ariyaratne (UK), A. Ward, P. Bhudia, V. Lund, D. Carnell
EP-1042